Document Detail


Inactivated poliovaccine: adverse reactions and antibody responses.
MedLine Citation:
PMID:  6246709     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Adverse reactions and antbody responses after inactivated poliovaccine were studied in 380 children. Fever reaction (greater than or equal to 37.5 degree C rectally) was recorded in 14% of children after the first poliovirus vaccination and in 19% after the second. Restlessness was reported in 15% and 14% of the chidren. Fever reaction exceeding 38.5 degree C was seen in 5% of the vaccines. Before the first vaccination at the age of six month 29% of the 48 children had antibodies against poliovirus type 1 and 2 and 43% against type 3. The first vaccination induced no significant changes in antibody titers. After the second vaccination antibody responses were low and 35%, 9%, and 35% remained seronegative to types 1, 2 and 3, respectively. After the third vaccination at the age of two years the respective geometric mean titers were 1:67, 1:335 and 1:48. No measurable antibodies were found to type 1 in 23%, to type 2 in 2%, and to type 3 in 10%. Only one child was triplenegative. All seronegative children were revaccinated and in all vaccinees a seroconversion ocurred two weeks after the booster dose. The combination of inactivated poliovaccine to DPT (Diphtheria, Tetanus, Pertussis) vaccine induced no significant change in poliovirus antibodies or in adverse reactions.
Authors:
O Ruuskanen; T T Salmi; M Stenvik; K Lapinleimu
Related Documents :
9203669 - Dose titration study of live attenuated varicella vaccine in healthy children. pennridg...
4564559 - Enteric immunization with live adenovirus type 21 vaccine. i. tests for safety, infecti...
1335639 - Inactivated hepatitis a vaccine: a safety and immunogenicity study in health profession...
1557929 - A randomized phase ii study of a new tick-borne encephalitis vaccine using three differ...
11068819 - Humoral immune responses and safety of experimental formulations of inactivated neospor...
6328729 - Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.
22819719 - Salmonella typhi ty21a bacterial ghost vector augments hiv-1 gp140 dna vaccine-induced ...
19081249 - Synthesis of 10-substituted triazolyl artemisinins possessing anticancer activity via h...
22505809 - Dendritic cells the tumor microenvironment and the challenges for an effective antitumo...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta paediatrica Scandinavica     Volume:  69     ISSN:  0001-656X     ISO Abbreviation:  Acta Paediatr Scand     Publication Date:  1980 May 
Date Detail:
Created Date:  1980-07-28     Completed Date:  1980-07-28     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0000211     Medline TA:  Acta Paediatr Scand     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  397-401     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Viral / analysis,  biosynthesis*
Child, Preschool
Diphtheria Toxoid / adverse effects
Fever / etiology
Humans
Pertussis Vaccine / adverse effects
Poliovirus / immunology
Poliovirus Vaccine, Inactivated / adverse effects*
Psychomotor Agitation
Tetanus Toxoid / adverse effects
Chemical
Reg. No./Substance:
0/Antibodies, Viral; 0/Diphtheria Toxoid; 0/Pertussis Vaccine; 0/Poliovirus Vaccine, Inactivated; 0/Tetanus Toxoid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Enhanced renal tubular calcium reabsorption independent of parathormone activity, in children on lon...
Next Document:  Para-influenza pneumonia in DiGeorge syndrome two years after thymic epithelial transplantation.